Research and Development

NattoPharma has a long-term documentation program for MenaQ7™products to investigate aspects of this very important compound in health and disease. Our research is conducted and supported by some of the most experienced vitamin K experts in the world. We strive to substantiate our MenaQ7 products and market information by scientific data and broad scientific competency in the vitamin K field.

An increasing number of vitamin K and menaquinone-7 scientific studies now substantiate present use. However, still more studies are necessary in bone and cardiovascular health --  as well as in new interesting areas where vitamin K2 may be important. This implies that further research is relevant and needed. Through a long-term agreement since 2006, NattoPharma has been in a close R&D collaboration with VitaK BV, University in Maastricht, the Netherlands. To strengthen our research NattoPharma also signed in 2013 a new and long-term research agreement with the Cardiovascular Research November Institute Maastricht, (CARIM), University of Maastricht. These agreements provide NattoPharma with the option to study mechanisms of action of vitamin K2 and to further evaluate the impact of Vitamin K2 on human health.

These R&D agreements and contacts with other outstanding medical institutions enable Nattopharma to explore and strengthen NattoPharma’s present recommendations and future use of MenaQ7 products. We are proud and excited to be part of and to stimulate the Vitamin K2 research in biochemical and clinical settings.

Photo of Dr. Cees Vermeer Dr. Cees Vermeer – one of the world leading experts on Vitamin K2
Dr. Vermeer studied Biochemistry at Leiden, where he also presented his PhD thesis (1974) on the initiation of protein biosynthesis in E coli.

In 1975 Dr. Vermeer was appointed at the Department of Biochemistry of the Universiteit Maastricht, where he has founded the Division on Vitamin K In 1984 he was appointed as an Associate Professor of Biochemistry and Principal Investigator at CARIM. In 1994 Dr. Vermeer was appointed as a temporary advisor of the World Health Organization and in 2001 he received the honorary title of Doctor honoris causa at the University of Medicine and Pharmacy "Iuliu Hatieganu" of the city of Cluj-Napoca, Romania. Moreover, in 2001 Dr. Vermeer founded the company VitaK BV, where he became the first CEO of the company. Read more on Wikipedia

Contact Us

For futher information, please contact:

Dr. Vladimir Badmaev
Head of R&D

NattoPharma contact information:
Kirkeveien 59B NO-1363 Høvik, Norway Fax: (+47) 67 20 02 51 Tel: (+47) 4000 9008 See on map
Created by:
Nutricon logo.
Search term: